Jingwen Hu

ORCID: 0000-0001-8789-3013
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neurogenesis and neuroplasticity mechanisms
  • Multiple Sclerosis Research Studies
  • Immune cells in cancer
  • S100 Proteins and Annexins
  • Immune Response and Inflammation
  • Stress Responses and Cortisol
  • Tryptophan and brain disorders
  • interferon and immune responses
  • Immune responses and vaccinations
  • Autoimmune and Inflammatory Disorders Research
  • Nerve injury and regeneration
  • Computational Drug Discovery Methods
  • Muscle metabolism and nutrition
  • Adipose Tissue and Metabolism
  • Treatment of Major Depression
  • Advanced Glycation End Products research
  • Muscle Physiology and Disorders
  • Genetics and Neurodevelopmental Disorders

Johns Hopkins Medicine
2023-2025

Johns Hopkins University
2023-2025

Georgetown University
2019-2025

Chengdu University of Traditional Chinese Medicine
2022-2023

Washington Center
2023

In multiple sclerosis (MS), microglia and macrophages within the central nervous system (CNS) play an important role in determining balance among demyelination, neurodegeneration, myelin repair. Phagocytic regenerative functions of these CNS innate immune cells support remyelination, whereas chronic maladaptive inflammatory activation promotes lesion expansion disability, particularly progressive forms MS. No currently approved drugs convincingly target CNS, contributing to lack therapies...

10.1126/scitranslmed.adk3434 article EN Science Translational Medicine 2025-01-08

Cerebral creatine deficiency syndrome (CCDS) is an inborn error of metabolism characterized by intellectual delays, seizures, and autistic-like behavior. However, the role endogenously synthesized on CNS development function remains poorly understood. Here, magnetic resonance spectroscopy adult mouse brains from both sexes revealed synthesis dependent expression enzyme, guanidinoacetate methyltransferase (GAMT). To identify Gamt -expressed cells, how affects postnatal development, we...

10.1523/jneurosci.2120-21.2022 article EN cc-by-nc-sa Journal of Neuroscience 2023-02-02

Abstract Regulation of myeloid cell activity is critical for successful myelin regeneration (remyelination) in demyelinating diseases, such as multiple sclerosis (MS). Here, we show aromatic alpha-keto acids (AKAs) generated from the amino acid oxidase, interleukin-4 induced 1 (IL4I1), promote efficient remyelination mouse models MS. During remyelination, cells upregulated expression IL4I1. Conditionally knocking out IL4I1 impaired efficiency. Mice lacking exhibited a reduction AKAs,...

10.1038/s41536-023-00345-9 article EN cc-by npj Regenerative Medicine 2024-01-02

Rosmarinic acid (RA), a natural phenolic compound with variety of bioactive properties. However, the antidepressant activity and mechanism RA remain unclear. The aim this study is to investigate effects potential mechanisms on chronic CORT injection induced depression-like behavior in mice. Male C57BL/6 J mice were intraperitoneally injected (10 mg/kg) orally given daily or 20 for 21 consecutive days. In vitro, HT22 cells exposed (200 μM) (12.5, 25 50 LY294002 (a PI3K inhibitor) ANA-12 TrkB...

10.1016/j.biopha.2023.115994 article EN Biomedicine & Pharmacotherapy 2023-12-09

ABSTRACT Multiple sclerosis (MS) is a chronic inflammatory disease characterized by immune‐mediated demyelination of the central nervous system, resulting in extensive neurological deficit and remyelination impairment. We have previously found that interleukin‐four induced one (IL4I1) protein modulates CNS inflammation enhances mouse models experimental demyelination. However, it remained unclear if IL4I1 regulates lymphocyte activity MS. To assess therapeutic potential MS, we investigated...

10.1002/prp2.70062 article EN cc-by-nc Pharmacology Research & Perspectives 2025-03-18

Significance To develop therapeutic strategies that enhance repair processes during central nervous system (CNS) injury, the molecular and cellular changes occurring at injury site must be determined. However, precisely isolating site, such as lesions in animal models of demyelination, has been difficult. We developed a simple powerful method to track analyze occur within lesion microenvironment over time. demonstrated neutral red-labeled could selectively isolated processed for detailed...

10.1073/pnas.1819343116 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2019-06-24

HMGB1 is a highly conserved, ubiquitous protein in eukaryotic cells. normally localized to the nucleus, where it acts as chromatin associated non-histone binding protein. In contrast, extracellular an alarmin released by stressed cells act danger molecular pattern (DAMP). We have recently determined that progenitor from multiple sclerosis patients exhibit cellular senescent phenotype and release which directly impaired maturation of oligodendrocyte (OPCs) myelinating oligodendrocytes (OLs)....

10.3389/fncel.2022.833186 article EN cc-by Frontiers in Cellular Neuroscience 2022-04-28

While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms disease. Meningeal inflammation is a recognized risk factor for cortical grey matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but mechanisms linking meningeal remain unclear. Here, we performed MRI-guided spatial transcriptomics mouse model autoimmune to...

10.7554/elife.88414.3 preprint EN 2024-09-30

Abstract In multiple sclerosis (MS), microglia and macrophages within the central nervous system (CNS) play an important role in determining balance between myelin repair demyelination/neurodegeneration. Phagocytic regenerative functions of these CNS innate immune cells support remyelination, whereas chronic maladaptive inflammatory activation promotes lesion expansion disability, particularly progressive forms MS. No currently approved drugs convincingly target CNS, contributing to critical...

10.1101/2023.08.28.555084 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-08-29

While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms disease. Meningeal inflammation is a recognized risk factor for cortical gray matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but mechanisms linking meningeal remain unclear. Here, we performed magnetic resonance imaging (MRI)-guided spatial...

10.7554/elife.88414 article EN cc-by eLife 2023-07-11

While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms disease. Meningeal inflammation is a recognized risk factor for cortical grey matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but mechanisms linking meningeal remain unclear. Here, we performed MRI-guided spatial transcriptomics mouse model autoimmune to...

10.7554/elife.88414.2 preprint EN 2024-06-18

While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms disease. Meningeal inflammation is a recognized risk factor for cortical gray matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but mechanisms linking meningeal remain unclear. Here, we performed magnetic resonance imaging (MRI)-guided spatial...

10.7554/elife.88414.4 article EN cc-by eLife 2024-10-30

Abstract While modern high efficacy disease modifying therapies have revolutionized the treatment of relapsing-remitting multiple sclerosis, they are less effective at controlling progressive forms disease. Meningeal inflammation is a recognized risk factor for cortical grey matter pathology which can result in disabling symptoms such as cognitive impairment and depression, but mechanisms linking meningeal remain unclear. Here, we performed MRI-guided spatial transcriptomics mouse model...

10.1101/2023.06.02.543421 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-06-06

This paper aimed to explore the antidepressant effect of essential oil from Schizonepeta tenuifolia Briq.(EOST) on treatment depression and its mechanism by using a combination network pharmacology mouse model lipopolysaccharide(LPS)-induced depression. The chemical components in EOST were identified gas chromatography-mass spectrometer(GC-MS), 12 active selected as study objects. targets related obtained Traditional Chinese Medicines Systems Pharmacology(TCMSP) SwissTargetPrediction...

10.19540/j.cnki.cjcmm.20221014.705 article EN PubMed 2023-02-01

ABSTRACT Multiple sclerosis (MS) is a chronic inflammatory disease characterized by immune mediated demyelination of the central nervous system, resulting in extensive neurological deficit and remyelination impairment. We have previously found that interleukin-four induced one (IL4I1) protein modulates CNS inflammation enhances mouse models experimental demyelination. However, it remained unclear if IL4I1 regulates lymphocyte activity MS. To assess therapeutic potential MS, we investigated...

10.1101/2023.09.17.558132 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-09-17
Coming Soon ...